Brazil MS Treatment Access Up 26% in 4 Years, Regional Gaps Persist

A study reports a 26% increase in multiple sclerosis treatment within Brazil's public health system (SUS) over four years, driven by expanded access to high-efficacy therapies. However, significant regional inequalities remain, with uneven distribution of treatment access across Brazilian states. The development signals progress in public health policy but highlights persistent disparities in healthcare delivery.